Expression of 17β-hydroxysteroid dehydrogenase type 5 in human ovary: A pilot study

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 1, 2000, Pages 61-64

  Qin, Ke Nan ^a   Rosenfield, Robert L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

17 hydroxysteroid dehydrogenase; Ovarian testosterone biosynthesis; Polycystic ovary syndrome

Indexed keywords

AMINO ACID; ANDROSTENEDIONE; DIHYDRODIOL DEHYDROGENASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TESTOSTERONE RELEASE; TESTOSTERONE SYNTHESIS;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENE LIBRARY; HUMANS; ISOENZYMES; MIDDLE AGED; OVARY; PILOT PROJECTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0033622471     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00067-2     Document Type: Article

References (24)

1. Labrie F., Luu-The V., Lin S.X., et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62:1997;148-158.
2. Peltoketo H., Isomaa V., Maentausta O., et al. Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 239:1988;73-77.
3. The V.L., Labrie C., Zhao H.F., et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17 Evidence of two mRNA species with distinct 5′-termini in human placenta . Mol Endocrinol. 3:1989;1301-1309.
4. Wu L., Einstein M., Geissler W.M., et al. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem. 268:1993;12964-12969.
5. Casey M.L., MacDonald P.C., Andersson S. 17 beta-Hydroxysteroid dehydrogenase type 2 Chromosomal assignment and progestin regulation of gene expression in human endometrium . J Clin Invest. 94:1994;2135-2141.
6. Mendonca B., Arnhold I., Bloise W., et al. 17β-Hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab. 84:1999;802-804.
7. Geissler W.M., Davis D.L., Wu L., et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet. 7:1994;34-39.
8. Stoffel-Wagner B., Watzka M., Steckelbroeck S., et al. Expression of 17 beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J Endocrinol. 160:1999;119-126.
9. Zhang Y., Word R.A., Fesmire S., et al. Human ovarian expression of 17 beta-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab. 81:1996;3594-3598.
10. Adamski J., Normand T., Leenders F., et al. Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem J. 311:1995;437-443.
11. Dufort I., Rheault P., Huang X.F., et al. Characteristics of a highly labile human type 5 17 beta-hydroxysteroid dehydrogenase. Endocrinology. 140:1999;568-574.
12. Khanna M., Qin K., Wang R.W., et al. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases. J Biol Chem. 270:1995;20162-20168.
13. Lin H.K., Jez J.M., Schlegel B.P., et al. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate Demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution . Mol Endocrinol. 11:1997;1971-1984.
14. Qin K., New M.I., Cheng K.C. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol. 46:1993;673-679.
15. Qin K., Khanna M., Cheng K.C. Structure of a gene coding for human dihydrodiol dehydrogenase/bile acid-binding protein. Gene. 149:1994;357-361.
16. Adashi E.Y., Hennebold J.D. Single-gene mutations resulting in reproductive dysfunction in women. N Engl J Med. 340:1999;709-718.
17. Harada N., Utsumi T., Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A. 90:1993;11312-11316.
18. Horton R., Tait J.F. Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest. 45:1966;301-313.
19. Bardin C., Lipsett M. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest. 46:1967;891-902.
20. 5-androstenediol as androgen prehormones in hirsute women. J Clin Endocrinol Metab. 37:1973;183-189.
21. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:1995;322-353.
22. Rosenfield R.L., Barnes R.B., Ehrmann D.A. Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 79:1994;1686-1692.
23. Pittaway D.E., Andersen R.N., Coleman S.A. Jr, et al. Human ovarian 17 beta-hydroxysteroid oxidoreductase activity A comparison of normal and polycystic ovarian tissues . J Clin Endocrinol Metab. 56:1983;715-729.
24. Barbieri R. Human ovarian 17-ketosteroid oxidoreductase Unique characteristics of the granulosa-luteal cell and stromal enzyme . Am J Obstet Gynecol. 166:1992;1117-1123.